lilly glp 1 drugs FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Eli Lilly Nails Oral GLP-1

This targeted microbiome approach reflects growing research connecting gut health with metabolic balance and long-term wellness

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to incomeraising questions for both Medicaid and Medicare.

Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.

SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy